Shuta Ohara
- Pulmonary and Respiratory Medicine top 5%
- Oncology top 10%
- Molecular Biology
- Cancer Research
- Pathology and Forensic Medicine
- Co-authors
- Tetsuya MitsudomiToshio FujinoKenichi SudaT. KogaMasaki ShimojiMasaya NishinoToshiki TakemotoMasato Chiba
- Topics
- Lung Cancer Treatments and Mutations (31 papers)HER2/EGFR in Cancer Research (7 papers)Lung Cancer Research Studies (6 papers)
- Journals
- SHILAP Revista de lepidopterologíaJournal of Hematology & OncologyCells
- Partner nations
- JapanUnited StatesAustria
In The Last Decade
Shuta Ohara
32 papers receiving 614 citations
Hit Papers
Peers
Comparison fields: 5 of 52
- Pulmonary and Respiratory Medicine 405
- Oncology 321
- Molecular Biology 299
- Cancer Research 108
- Pathology and Forensic Medicine 68
Countries citing papers authored by Shuta Ohara
This map shows the geographic impact of Shuta Ohara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuta Ohara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuta Ohara more than expected).
Fields of papers citing papers by Shuta Ohara
This network shows the impact of papers produced by Shuta Ohara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuta Ohara. The network helps show where Shuta Ohara may publish in the future.
Co-authorship network of co-authors of Shuta Ohara
This figure shows the co-authorship network connecting the top 25 collaborators of Shuta Ohara. A scholar is included among the top collaborators of Shuta Ohara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuta Ohara. Shuta Ohara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 6 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 9 | |
| 6 | 4 | |
| 7 | 7 | |
| 8 | 10 | |
| 9 | 1 | |
| 10 | 7 | |
| 11 | 10 | |
| 12 | KRAS Secondary Mutations That Confer Acquired Resistance to KRAS G12C Inhibitors, Sotorasib and Adagrasib, and Overcoming Strategies: Insights From In Vitro Experimentsbreakdown → | 167 |
| 13 | 7 | |
| 14 | 6 | |
| 15 | 15 | |
| 16 | 0 | |
| 17 | 114 | |
| 18 | 4 | |
| 19 | 1 | |
| 20 | 11 |
About Shuta Ohara
Shuta Ohara is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Internal Medicine, having authored 37 papers that have together received 627 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (31 papers), HER2/EGFR in Cancer Research (7 papers) and Lung Cancer Research Studies (6 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (405 citations), Oncology (321 citations) and Hepatology (59 citations). Shuta Ohara has collaborated with scholars based in Japan, United States and Austria. Frequent co-authors include Tetsuya Mitsudomi, Toshio Fujino, Kenichi Suda, T. Koga, Masaki Shimoji, Masaya Nishino, Toshiki Takemoto, Masato Chiba, Junichi Soh and Akira Hamada. Their work appears in journals such as SHILAP Revista de lepidopterología, Journal of Hematology & Oncology and Cells.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.